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Abstract Using the scrape-loading technique we show that
tolbutamide and glybenzcyclamide, two inhibitors of the K+
channel sensitive to ATP (K-ATP channel), partially prevent the
inhibition of gap junction permeability promoted by Ca2+ in
cultured astrocytes. This effect was dose-dependent, reaching a
maximum at 400 WM and 1 WM of tolbutamide and glybenzcy-
clamide, respectively. The presence of the Ca2+ ionophore A-
23187 strongly reduced the concentration of Ca2+ required to
block gap junction permeability but did not abolish the effect of
tolbutamide and glybenzcyclamide. These results suggest that the
effect of these two compounds are not brought about by control
of the intracellular concentration of Ca2+ but probably by the
promotion of plasma membrane depolarization.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Astrocytes are extensively coupled through the intermem-
brane channels known as gap junctions [1^3]. These intercel-
lular channels allow the passage from cell to cell of ions and
small molecules, such as second messengers [4] or energy me-
tabolites [5,6] (reviewed in [7,8]). The permeability of gap
junctions is subject to regulation, and plays an important
role in brain metabolism and development [9]. A number of
physiological factors have been described as regulators of the
permeability of gap junctions in astrocytes (reviewed in [10] ;
see also [11,12]). Although the ultimate mechanism through
which these agents inhibit gap junction permeability is not
known, the activation of protein kinase C, the release of
arachidonic acid and/or the increase in cytoplasmic Ca2 con-
centrations have been proposed as possible transduction path-
ways (for a review see [10]). Thus, gap junction permeability
in astrocytes is inhibited by Ca2 although the e¡ect of this
cation is prevented by the depolarization of the plasma mem-
brane caused by either increased extracellular K concentra-
tions or the activation of ionotropic glutamate receptors [13].
One of the mechanisms involved in preserving membrane
potential is the activity of the K-ATP channel (for a review
see [14]). The K-ATP channel is composed of two subunits,
KIR (inwardly rectifying K channel) and SUR (sulfonylurea
receptor) [15], the latter conferring the channel sensitivity to
ATP, sulfonylureas, and to an endogenous ligand, endosul-
¢ne. The existence of the K-ATP channel has been reported in
the CNS [16], which is sensitive to sulfonylureas [17,18] and to
endosul¢ne [19].
In a previous work we showed that the decrease in intra-
cellular concentrations of ATP due to treatment with antimy-
cin diminishes gap junction permeability in cultured rat astro-
cytes through a mechanism that is mediated by Ca2 [11].
Because the intracellular concentrations of ATP regulate the
open/closed state of the K-ATP channel and the subsequent
change in membrane potential, the aim of this work was to
investigate whether the K-ATP channel modulates gap junc-
tion permeability in astrocytes.
2. Materials and methods
2.1. Reagents
Dulbecco’s modi¢ed Eagle’s medium (DMEM), penicillin, strepto-
mycin, poly-L-lysine, DNase, bovine serum albumin (BSA), ionophore
A-23187, tolbutamide, valinomycin and lucifer yellow were purchased
from Sigma (St. Louis, MO, USA). Fetal calf serum (FCS) and tryp-
sin were obtained from Serva Boehringer Ingelheim (Heidelberg, Ger-
many). Glybenzcyclamide was obtained from Aldrich (Milwaukee,
WI, USA). Other chemicals were purchased from Sigma or Merck
(Darmstadt, Germany).
2.2. Animals
Albino Wistar rats, fed ad libitum on a stock laboratory diet (49.8%
carbohydrates, 23.5% protein, 3.7% fat, 5.5% minerals and added
vitamins and amino acids; w/w) were used for the experiments.
Rats were maintained on a 12 h light-dark cycle.
2.3. Cell cultures
Astrocytes in primary culture were prepared from the brains of 1^2-
day-old Wistar rats as previously described [20]. In brief, animals were
decapitated and their brains immediately excised. After removing the
meninges and blood vessels, the forebrains were placed in Earle’s
balanced solution containing 20 Wg/ml DNase and 0.3% (w/v) BSA.
The tissue was minced, washed, centrifuged and incubated in 0.025%
(w/v) trypsin and 60 Wg/ml DNase for 15 min at 37‡C in a shaking
water bath. Trypsinization was completed by adding DMEM contain-
ing 10% (v/v) FCS. The tissue was then dissociated by trituration,
passing it eight times through a siliconized Pasteur pipette and the
supernatant cell suspension was recovered. This procedure was re-
peated and the resulting cell suspension was centrifuged. Culture me-
dium was DMEM supplemented with 10% (v/v) FCS, penicillin (50 U/
ml) and streptomycin (50 Wg/ml). The cell pellet was resuspended in a
known volume of culture medium and plated on poly-L-lysine-coated
culture £asks (150 cm2) at a density of 105 cells/cm2. Cells were in-
cubated at 37‡C in an atmosphere of 95% air/5% CO2 with 90^95%
humidity. After 5 days cells were replated onto petri dishes (diameter
3.5 cm) at a density of 1.5U106 cells per petri dish. Cytosine arabino-
side (10 WM) was added to the culture medium for 2 days to avoid the
growth of microglia and cells from the O-2A (oligodendrocyte and
type-2 astrocyte) lineage. The culture medium was renewed with a
fresh one twice a week. Scrape-loading experiments were performed
2 weeks after seeding, once the cells were highly coupled. Under our
experimental conditions, when con£uence was reached, 90^95% of the
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cells were astrocytes, as determined by immunostaining against glial
¢brillary acidic protein [20,21].
2.4. Assessment of junctional communication
Gap junction permeability was determined by the scrape-loading/
dye transfer technique described by El-Fouly et al. [22]. In brief, the
culture medium was removed and cells were washed with an ionic
solution (130 mM NaCl, 2.8 mM KCl, 1 mM CaCl2, 2 mM MgCl2
and 10 mM HEPES, pH 7.2) and preincubated at room temperature
(V22‡C) in ionic solution. After 5 min, this solution was removed
and cells were further incubated in the same ionic solution without
Ca2 [23] for 2 min. Scrape-loading was performed by scraping
the cell layer with a broken razor blade in the Ca2-free ionic solution
containing 1 mg/ml of lucifer yellow CH (Sigma), a highly £uores-
cent dye that passes through gap junctions from loaded cells to neigh-
boring ones, but not through the plasma membrane. After 1 min,
the dye solution was removed and the cells were carefully washed
with excess ionic solution. Eight minutes after scraping, photo-
micrographs (Kodak Tmax 400 ASA) were taken using an inverted
£uorescent microscope equipped with appropriate ¢lters (Diaphot,
Nikon).
To estimate gap junction permeability, three side-by-side photomi-
crographs of the center of the dish were taken. Negatives were digi-
tized on a scanner and microphotographs were analyzed using image-
analyzer software (NIH Image, Wayne Rasband, National Institutes
of Health, Bethesda, MD, USA). Data were quanti¢ed by measuring
the £uorescent areas of the digitized images by computation of the
surface occupied by the dye. All pictures were large enough to cover
the limit of dye di¡usion. In each experiment, the £uorescent area
occupied by the ¢rst line of loaded cells was subtracted from the
rest of the experimental conditions. The £uorescent area found in
the untreated cells was considered 100% (control). The e¡ects caused
by the di¡erent treatments on junction permeability were expressed as
percentages of the control. For each experimental condition, the size
of the £uorescent area was averaged from the data obtained in the
adjacent images.
2.5. Cell treatments
The compounds tested were CaCl2 (0.01^5 mM), 130 mM KCl,
tolbutamide (100^600 WM), glybenzcyclamide (0.1^1 WM), 2 WM vali-
nomycin and 5 WM of the Ca2 ionophore A-23187. Stock solutions
of these compounds were dissolved in water except the Ca2 iono-
phore A-23187 and valinomycin, which were dissolved in dimethyl
sulfoxide and absolute ethanol, respectively. Tolbutamide and gly-
benzcyclamide were preincubated for 30 min in the culture medium
at 37‡C. The e¡ects of valinomycin and A-23187 were tested by pre-
incubation for 10 min in the ionic solution at room temperature. All
these compounds were added to the solutions used throughout the
scrape-loading procedure. The e¡ects of CaCl2 and KCl on gap junc-
tion permeability were tested by adding them, at the desired concen-
trations, to the ionic solution containing lucifer yellow. In the solu-
tions containing 130 mM KCl, NaCl was reduced to 5 mM. For each
experimental condition, an equal amount of the vehicle was used as a
control. The e¡ects caused by the di¡erent treatments on junction
permeability were analyzed quantitatively by measuring the £uores-
cent area under each experimental condition, expressing this value as
a percentage of that obtained with the controls. Statistical analyses
were performed using Student’s t-test.
3. Results
Astrocytes were extensively coupled, as shown by the high
number of £uorescent cells observed after scrape-loading with
lucifer yellow (Fig. 1a). Fig. 1b shows that in the presence of
1.5 mM CaCl2, lucifer yellow was restricted to the ¢rst row of
loaded cells, indicating that junctional communication in as-
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Fig. 1. Fluorescence photomicrographs of cultured rat astrocytes after scrape-loading. Astrocytes were incubated in the absence (a, b) or in the
presence of 400 WM tolbutamide (c) or 1 WM glybenzcyclamide (d). Gap junction permeability was determined by the scrape-loading technique
as described in Section 2. Scrape-loading was performed in the ionic solution containing lucifer yellow, in the absence (a) or in the presence of
1.5 mM CaCl2 (b, c, d). Microphotographs were taken using appropriate ¢lters for lucifer yellow. Bar = 70 Wm.
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trocytes was inhibited. Our results show that CaCl2 inhibited
gap junction communication in a dose-dependent manner
(Fig. 2a), the maximum e¡ect being reached when the concen-
tration of CaCl2 in the scrape solution was about 1.5 mM. In
order to facilitate the access of Ca2 into the cell, the astro-
cytes were treated with the Ca2 ionophore A-23187 and the
scrape was then performed in a solution with increasing con-
centrations of CaCl2 (Fig. 2b). Under these circumstances, the
presence of CaCl2 decreased the lucifer yellow £uorescent area
in a dose-dependent manner, the maximum e¡ect being
reached at concentrations of CaCl2 of about 0.1 mM. Thus,
the presence of the Ca2 ionophore decreased the concentra-
tion of CaCl2 required for the inhibition of gap junction per-
meability by approximately 15-fold.
In order to con¢rm previous works reporting that junction-
al inhibition brought about by Ca2 is dependent on mem-
brane polarity [13], some experiments were carried out after
depolarization of the plasma membrane. To do so, the K
concentration was increased (130 mM KCl) while the Na
concentration was lowered (5 mM NaCl) in the ionic solution
containing lucifer yellow. Again, the scrape was performed in
this solution with increasing concentrations of CaCl2 (Fig.
2c). Under these circumstances, CaCl2 was able to reduce
the lucifer yellow £uorescent area in a dose-dependent man-
ner, although the concentration of CaCl2 needed to reach a
maximum e¡ect was approximately 4 mM, i.e. nearly three-
fold higher than the concentration of CaCl2 required in the
presence of low K concentrations. Moreover, in the presence
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Fig. 2. E¡ect of increasing Ca2 concentrations on gap junction per-
meability in cultured astrocytes. Gap junction permeability was de-
termined by the scrape-loading technique as described in Section 2.
Increasing concentrations of CaCl2 were added to the ionic solution
containing lucifer yellow (a, b, c). Some experiments were carried
out in the presence of 5 WM of the Ca2 ionophore A-23187 (b).
Some scrapes were performed with the ionic solution containing
lucifer yellow, 130 mM KCl and 5 mM NaCl (c). The lucifer yel-
low £uorescent area was quanti¢ed and the results from at least
three di¡erent cultures were expressed as percentages of the con-
trols. The values were adjusted to the following functions:
(a) y = 95.130.11x+2.8U1035x2, P6 0.001;
(b) y = 88.631.4x+5.0U 1033x2, P6 0.001;
(c) y = 15830.07x+8.2U1036x2, P6 0.001.
Fig. 3. E¡ect of tolbutamide and glybenzcyclamide in the Ca2-elic-
ited inhibition of gap junction permeability. Astrocytes were incu-
bated with increasing concentrations of tolbutamide (a) or glybenz-
cyclamide (b). 1.5 mM CaCl2 was added to the ionic solution
containing lucifer yellow. Scrape-loading was performed as described
in Section 2. The lucifer yellow £uorescent area was quanti¢ed and
the results from at least three di¡erent cultures were expressed
as percentages of the controls. The values were adjusted to the
following functions: (a) y = 1.25+0.13x31.4U1034x2, P6 0.001;
(b) y = 0.5+0.04x317U1035x2, P6 0.001. EC50, concentration that
produces 50% of the maximal e¡ect.
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of 130 mM KCl, lucifer yellow was never restricted to the ¢rst
row of loaded cells because lucifer yellow still di¡used
through approximately 20% of the £uorescent area in the
presence of 5 mM CaCl2, (Fig. 2c). It should be mentioned
that the presence of high extracellular K elicited an approx-
imately 100% increase in the £uorescent area as compared
with untreated cells (Fig. 2c).
Our results show that treatment with tolbutamide (Fig. 1c)
or glybenzcyclamide (Fig. 1d) partially prevents the inhibitory
e¡ect of Ca2 on gap junctional permeability. Thus, when 1.5
mM CaCl2 was present in the scrape solution, the lucifer
yellow £uorescent area was increased from 0% to approxi-
mately 30% by the presence of increasing concentrations of
tolbutamide (Fig. 3a). The e¡ect of tolbutamide was dose-
dependent and reached a maximum at tolbutamide concen-
trations of about 400 WM. These values were adjusted to a
second order polynomial function; using this function the
concentration of tolbutamide that produces 50% of its max-
imal e¡ect (EC50) was calculated to be 63.3 WM. It should be
mentioned that treatment with 400 WM tolbutamide promoted
an increase in the lucifer yellow £uorescent area of 19.8 þ 2.8%
(n = 10; P6 0.01) as compared to the control. Similar results
were obtained with another sulfonylurea, glybenzcyclamide,
which increased the spreading of lucifer yellow, measured as
£uorescent area, by 15.8 þ 2.8% (n = 7; P6 0.05). In addition,
in the presence of 1.5 mM CaCl2, the £uorescent area was
increased from 0% to approximately 20% by increasing gly-
benzcyclamide concentrations (Fig. 3b). This e¡ect was also
dose-dependent, reaching a maximum at concentrations of
glybenzcyclamide of about 1 WM. The data obtained from
the glybenzcyclamide-treated cells were also ¢tted to a second
order polynomial function, the EC50 being 0.4 WM. Therefore,
the EC50 for glybenzcyclamide was about 1000-fold lower
than that of tolbutamide, in agreement with their reported
a⁄nities for the sulfonylurea receptor [18,24].
In the presence of the Ca2 ionophore A-23187, tolbuta-
mide and glybenzcyclamide still were able to partially prevent
the inhibitory e¡ect of Ca2 on astrocytic gap junction per-
meability (Fig. 4b). However, in the presence of valinomycin,
a K-speci¢c ionophore that equilibrates K concentrations
across the plasma membrane, sulfonylureas were not able to
prevent the inhibitory e¡ect of Ca2 on gap junctional perme-
ability (Fig. 4c).
4. Discussion
The potassium channel sensitive to ATP (K-ATP) com-
prises a K pore (KIR) and a regulating subunit (SUR)
that confers the channel sensitivity to ATP, sulfonylureas
and endosul¢ne (for a recent review see [15]). Our results
show that the presence of tolbutamide or glybenzcyclamide,
two well-known sulfonylureas, signi¢cantly decreases the in-
hibitory e¡ect of Ca2 on gap junction permeability in astro-
cytes (Figs. 1 and 3). These observations suggest that the K-
ATP channel controls permeability through gap junctions in
astrocytes. Indeed, the increase in extracellular K concentra-
tions also decreased the inhibitory e¡ect of Ca2 (Fig. 2c and
[13]), suggesting that the e¡ect of Ca2 is associated with the
occurrence of an outward £ux of K. In addition, the pres-
ence of valinomycin, a potassium ionophore that equilibrates
K concentrations across the plasma membrane, abolished
the preventive e¡ect of tolbutamide or glybenzcyclamide on
the inhibition of gap junction permeability caused by Ca2
(Fig. 4c). This is consistent with the idea that the K-ATP
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Fig. 4. E¡ect of sulfonylureas on the inhibition of gap junction per-
meability promoted by Ca2 in the absence (a), or in the presence
of the Ca2 ionophore A-23187 (b) or valinomycin (c). Astrocytes
were exposed to 1.5 mM CaCl2, 1.5 mM CaCl2 plus 400 WM tolbu-
tamide or 1.5 mM CaCl2 plus 1.5 WM glybenzcyclamide in the ab-
sence (a) or in the presence of 5 WM A-23187 (b) or 2 WM valino-
mycin (c). Scrape-loading was performed as described in Section 2.
The lucifer yellow £uorescent area was quanti¢ed and the results
from at least three di¡erent cultures were expressed as percentages
of the controls and are means þ S.E.M. Statistical di¡erences be-
tween the values obtained with di¡erent treatments as compared
with those obtained in the presence of 1.5 mM CaCl2 were ex-
pressed as ***P6 0.001. Statistical di¡erences between the values
obtained in the absence (a) and in the presence of the Ca2-iono-
phore A-23187 (b; not signi¢cant) or valinomycin (c) were expressed
as P6 0.001. Tolb, tolbutamide; gly, glybenzyclamide; Val, valino-
mycin.
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channel would control the regulation of gap junction perme-
ability brought about by Ca2.
It could be speculated that the K-ATP channel controls gap
junction permeability by modulating Ca2 concentrations in
the cytosol. If so, the inhibition of the K-ATP channel would
prevent the entry of Ca2, resulting in an enhancement of gap
junction permeability. Contrariwise, the activity of the K-ATP
channel would allow Ca2 entry which inhibits gap junction
permeability. However, this does not seem the mechanism
operating under these circumstances, because tolbutamide or
glybenzcyclamide still decreased the e¡ect of Ca2 in the pres-
ence of the Ca2 ionophore A-23187 (Fig. 4b), suggesting that
the e¡ect of K-ATP channel on gap junction permeability is
not associated with changes in cytosolic free Ca2 concentra-
tions. Instead, membrane depolarization caused by the inhib-
ition K-ATP channel would prevent the inhibition of gap
junction permeability caused by Ca2, a fact consistent with
the idea that the inhibitory e¡ect of Ca2 requires a polarized
membrane [13]. In agreement with this, membrane hyperpola-
rization caused by valinomycin alone sharply decreased gap
junction permeability (Fig. 4c; [13]) while the depolarization
caused by increasing extracellular concentrations of K sharp-
ly increased gap junction permeability (Fig. 2c; [13]). It may
therefore be be concluded that the K-ATP channel regulates
gap junction permeability by controlling membrane potential
through a mechanism that is independent of but mandatory in
the Ca2 e¡ect.
Because tolbutamide and glybenzcyclamide mimic the ef-
fects of ATP on the K-ATP channel, it may be suggested
that intracellular ATP concentrations regulate gap junction
permeability [11] through the control of the K-ATP channel.
The physiological meaning of this e¡ect is not evident but it is
tempting to speculate that the energy status of the astrocyte
would be able to regulate intercellular communication
through gap junctions. When the energy status of the astro-
cyte was su⁄cient to sustain its own metabolic machinery, gap
junction permeability would increase to allow the passage of
metabolites [5,6] and signals [25] to adjacent cells. However, if
the energy reserves of the astrocyte were compromised, ATP
concentrations would decrease, resulting in a drop in gap
junction permeability [11].
We have previously suggested that astrocytic gap junctions
play an important role in ‘pipelining’ metabolic substrates
through the CNS by acting like waterway locks that allow
the establishment of a cell-to-cell metabolite gradient that
fuelled the transport of substrates to targeted neurons [5,6].
If so, ATP concentrations may regulate the open/closed state
of the ‘locks’ by controlling the activity of the K-ATP chan-
nel. Once the incoming substrates have ful¢lled the energy
requirements of the cells, gap junction permeability would
increase to allow spared metabolic substrates to pass to ad-
jacent cells, thus distributing energy and carbon skeletons
through the CNS.
In conclusion, the K-ATP channel may play an important
role in controlling the transport of ions, metabolites and sig-
nals through the CNS, thus regulating the crucial collabora-
tion between astrocytes and neurons. This also allocates an
important role to endosul¢ne, an endogenous putative phys-
iological inhibitor of the K-ATP channel [19].
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